4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-24-006982
EVP & Chief Medical Officer sold 14,568 shares at $10.05 ($146,344)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip EVP & Chief Medical Officer | 2024-02-22 | Sale 10b5-1 | −14,568 | $10.05 | $146,344 | 250,111 | D |
| Open-market sales · 14,568 sh · avg $10.05 · $146,344 | |||||||
Loading xslF345X05/wk-form4_1708993886.xml…